alexa Monitoring The Drug Toxicity Of Antineoplastic Chemotheraphy In Children With Cancer | 14455
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
November 18-19, 2013 Hilton San Antonio Airport, TX, USA

Ioan Magyar, Cristian Sava, Ariana Szilagyi and Diana Uivarosan
ScientificTracks Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.007
Abstract
Introduction: Although neoplastic diseases are not very frequent in juvenile pathology (8,600/year in patients under the age of 14 and 3,700/year in patients between the ages of 15 and 18, in the U.S. statistics), antineoplastic chemotherapy continues to be quite aggressive in children despite a good therapeutic results. Material and Methods: Our study focused on the toxicity of antineoplastic chemotherapy on 42 children between the ages of 3 and 18, with different kind and stages of cancer.The adverse drug reactions (A.D.R.s) were recorded in a special chemotherapy side effects sheet, recommended by World Health Organization. These A.D.R.s are divided into 5 stages (0-4). The data were processed using chi square test. Results and Discussions: Most patients were diagnosed with acute lymphoblastic leukemia (22; 52.4%). The rest of the patients were diagnosed with Ewing sarcoma (9; 21.4%), Hodgkin lymphoma (7; 16.7%), osteosarcoma (3; 7.1%), and non-Hodgkin lymphoma (1; 2.4%). All patients underwent different antineoplastic chemotherapy treatments according to the type of cancer, its stage and the international protocols on the respective case. Most patients presented hematological toxicity (22, 52.4%) and gastrointestinal toxicity (22, 52.4%). Afterwards come the cutaneous side effects (16, 38.1%) hepatic toxicity (14, 33.3%) and infection (14, 33.3%) complications. Neurological toxicity was present in 5 cases, while renal toxicity was present in 4 cases. As for associated toxicity, most patients (14 respectively) presented three types: hematological, gastrointestinal, and infectious toxicity. Other 8 patients presented 4 associations of toxicity, 6 patients had 5 associations, while other 6 patients had 6 toxicity associations. The toxicity level, on a scale of 0 to 4, appears very high in the case of leukopenia (level 4, under 1000/mm3) [10; 23.8%], in the case of a haemoglobin decrease (level 4, below 6.5g/dl) [5; 11.9%], and in the case of granulocytopenia (level 4, below 55/mm3) [7; 16.7%]. Conclusions: By strict and standard monitoring of the adverse side effects of the antineoplastic chemotherapy, certain correlations can be made regarding a higher or lower toxicity level of certain therapeutic regimens. At the same time, we can select the therapeutic regimens that should accomplish the highest benefit/risk ratio.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version